Skip to main content

Home/ PharmaMics/ Group items tagged #beigene

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
ramchintamaneni

ESMO 2019: BeiGene presents data on tislelizumab and pamiparib - 0 views

www.clinicaltrialsarena.com/...-on-tislelizumab-and-pamiparib

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #beigene #tislelizumab #pamiparib

shared by ramchintamaneni on 17 Oct 19 - No Cached
  • ramchintamaneni on 17 Oct 19
     
    Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib.
1 - 1 of 1
Showing 20▼ items per page